Red Flags for Soft Tissue Sarcoma

Primary Red Flag Criteria

The National Health Service recommends that any soft tissue mass increasing in size, size >5 cm, deep location, and pain should be urgently investigated for soft tissue sarcoma, with increasing size being the single most important warning sign 1, 2
The British Medical Association suggests that an unexplained lump that is enlarging warrants urgent ultrasound within 2 weeks, as this is the most predictive feature of malignancy 1, 2
Masses exceeding 5 cm in diameter have significantly higher malignancy risk and require direct specialist referral, according to the Royal College of Radiologists 1, 2
Any mass located beneath the deep fascia, particularly in the thigh or retroperitoneum, is highly concerning for sarcoma, as stated by the American College of Surgeons 1, 2
The presence of pain, especially night pain in bone lesions, is a red flag requiring investigation, as recommended by the British Orthopaedic Association 1, 2, 3

The typical presentation characteristics of soft tissue sarcoma include a painless enlarging mass, with the most common presentation being a painless mass, though the painless nature can be deceptive and lead to delayed diagnosis, according to the National Institute for Health and Care Excellence 1, 2
The median size at diagnosis remains over 9 cm, reflecting the challenge of early clinical recognition, particularly for deep-seated lesions, as reported by the European Society of Medical Oncology 1, 2

Certain locations carry heightened concern, including retroperitoneal or intra-abdominal masses, which must be referred to a specialist sarcoma MDT before surgical treatment, as recommended by the European Society of Surgical Oncology 1, 2
Lower limb deep masses, particularly atypical lipomatous tumors, tend to be larger, deep-seated, and located in the lower limb, according to the Musculoskeletal Tumor Society 1, 2
Sun-exposed areas are more common for cutaneous angiosarcomas and atypical fibroxanthoma due to UV radiation, as stated by the Skin Cancer Foundation 1, 2

Prior therapeutic irradiation is the most important environmental risk factor, with radiation-induced sarcomas appearing many years after radiotherapy and having worse outcomes than sporadic sarcomas, as reported by the International Commission on Radiological Protection 1, 2
Chronic lymphoedema is associated with cutaneous angiosarcoma, also known as Stewart-Treves syndrome, according to the Lymphoedema Support Network 1, 2
Genetic syndromes, such as Li-Fraumeni syndrome and hereditary retinoblastoma, increase sarcoma risk, as stated by the National Cancer Institute 2

Bone involvement, including bone destruction, new bone formation, periosteal swelling, or soft tissue swelling on X-ray, requires further investigation, as recommended by the Royal College of Radiologists 3
Ultrasound findings suggestive of malignancy mandate suspected cancer pathway referral within 2 weeks, according to the National Institute for Health and Care Excellence 1, 2
Heterogeneous enhancement, irregular, multilobulated masses with intralesional calcifications on CT strongly suggest potential sarcoma, as reported by the European Society of Radiology 4

Assuming lipomas are always benign can lead to delayed diagnosis, as atypical lipomatous tumors can mimic benign lipomas but require different surgical management, according to the American College of Surgeons 1, 2
Dismissing masses with recent trauma history can lead to delayed investigation, as a history of recent injury does not exclude sarcoma, as stated by the British Orthopaedic Association 3
Relying on "normal" X-rays can lead to delayed diagnosis, as a normal X-ray does not exclude sarcoma, and persistent pain or mass requires urgent MRI or specialist referral, according to the Royal College of Radiologists 3

Any ultrasound findings suggestive of soft tissue sarcoma or uncertain findings with persistent clinical concern warrant suspected cancer pathway referral for appointment within 2 weeks, as recommended by the National Institute for Health and Care Excellence 1, 2
Patients under 40 years with suspected sarcoma should be referred urgently to a bone sarcoma center, according to the European Musculoskeletal Oncology Society 3

Night pain in bone lesions is a specific red flag for primary malignant bone tumors requiring investigation, as stated by the British Orthopaedic Association 3
Pathological fracture, particularly in giant cell tumors or other bone lesions, indicates aggressive behavior, according to the Musculoskeletal Tumor Society 3

Any patient with an unexplained lump that is increasing in size should receive a direct access ultrasound scan within 2 weeks, as this is the single most important first-line diagnostic tool for triaging soft tissue masses suspicious for sarcoma, according to the British Journal of Cancer guidelines 5
Ultrasound serves as the mandatory initial imaging modality for suspected soft tissue sarcomas in adults presenting with red flag features, such as increasing size, larger than 5 cm, deep location, or pain, as recommended by the British Journal of Cancer 5

Consider a suspected cancer pathway referral within 2 weeks if ultrasound findings are suggestive of soft tissue sarcoma, uncertain, or if clinical concern persists, particularly with red flag features, as suggested by the British Journal of Cancer 5

For retroperitoneal or intra-abdominal masses, ultrasound is inadequate and requires CT or MRI and immediate referral to a specialist sarcoma MDT before any biopsy or surgical treatment, according to the British Journal of Cancer 5
After positive or indeterminate ultrasound, patients require CT chest for staging if sarcoma is confirmed or highly suspected, as recommended by the British Journal of Cancer 5